nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGB—mammary gland—sarcoma	0.0193	0.0684	CbGeAlD
Sucralfate—FGA—Podofilox—Etoposide—sarcoma	0.0162	1	CbGdCrCtD
Sucralfate—EGF—endothelium—sarcoma	0.015	0.0531	CbGeAlD
Sucralfate—FGB—embryo—sarcoma	0.0132	0.0467	CbGeAlD
Sucralfate—EGF—mammary gland—sarcoma	0.0121	0.0428	CbGeAlD
Sucralfate—FGB—hematopoietic system—sarcoma	0.0118	0.0417	CbGeAlD
Sucralfate—FGA—embryo—sarcoma	0.0113	0.04	CbGeAlD
Sucralfate—FGF2—mammary gland—sarcoma	0.0107	0.0377	CbGeAlD
Sucralfate—FGA—hematopoietic system—sarcoma	0.0101	0.0357	CbGeAlD
Sucralfate—FGG—testis—sarcoma	0.00836	0.0296	CbGeAlD
Sucralfate—FGB—lymphoid tissue—sarcoma	0.00829	0.0294	CbGeAlD
Sucralfate—EGF—embryo—sarcoma	0.00825	0.0292	CbGeAlD
Sucralfate—FGG—liver—sarcoma	0.0079	0.028	CbGeAlD
Sucralfate—FGF2—myometrium—sarcoma	0.00756	0.0268	CbGeAlD
Sucralfate—FGB—bone marrow—sarcoma	0.00755	0.0267	CbGeAlD
Sucralfate—EGF—hematopoietic system—sarcoma	0.00736	0.0261	CbGeAlD
Sucralfate—FGA—lymphoid tissue—sarcoma	0.0071	0.0251	CbGeAlD
Sucralfate—EGF—connective tissue—sarcoma	0.00709	0.0251	CbGeAlD
Sucralfate—EGF—smooth muscle tissue—sarcoma	0.00648	0.023	CbGeAlD
Sucralfate—FGA—bone marrow—sarcoma	0.00646	0.0229	CbGeAlD
Sucralfate—FGB—testis—sarcoma	0.00645	0.0228	CbGeAlD
Sucralfate—EGF—skin of body—sarcoma	0.0064	0.0227	CbGeAlD
Sucralfate—FGB—liver—sarcoma	0.0061	0.0216	CbGeAlD
Sucralfate—FGG—lymph node—sarcoma	0.00606	0.0214	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—sarcoma	0.00572	0.0202	CbGeAlD
Sucralfate—EGF—cardiac atrium—sarcoma	0.00559	0.0198	CbGeAlD
Sucralfate—EGF—uterus—sarcoma	0.00556	0.0197	CbGeAlD
Sucralfate—FGA—testis—sarcoma	0.00552	0.0196	CbGeAlD
Sucralfate—FGA—liver—sarcoma	0.00522	0.0185	CbGeAlD
Sucralfate—EGF—lymphoid tissue—sarcoma	0.00518	0.0183	CbGeAlD
Sucralfate—FGF2—uterus—sarcoma	0.00491	0.0174	CbGeAlD
Sucralfate—EGF—tendon—sarcoma	0.00487	0.0172	CbGeAlD
Sucralfate—FGF2—tendon—sarcoma	0.0043	0.0152	CbGeAlD
Sucralfate—ALB—mammary gland—sarcoma	0.00418	0.0148	CbGeAlD
Sucralfate—EGF—testis—sarcoma	0.00403	0.0143	CbGeAlD
Sucralfate—EGF—liver—sarcoma	0.00381	0.0135	CbGeAlD
Sucralfate—FGF2—testis—sarcoma	0.00356	0.0126	CbGeAlD
Sucralfate—EGF—lymph node—sarcoma	0.00292	0.0104	CbGeAlD
Sucralfate—Extravasation—Thiotepa—sarcoma	0.00272	0.0644	CcSEcCtD
Sucralfate—Extravasation—Dactinomycin—sarcoma	0.0027	0.064	CcSEcCtD
Sucralfate—FGF2—lymph node—sarcoma	0.00258	0.00913	CbGeAlD
Sucralfate—Extravasation—Vincristine—sarcoma	0.00241	0.0571	CcSEcCtD
Sucralfate—Extravasation—Mitoxantrone—sarcoma	0.00235	0.0557	CcSEcCtD
Sucralfate—Phlebitis—Dactinomycin—sarcoma	0.00199	0.047	CcSEcCtD
Sucralfate—Extravasation—Etoposide—sarcoma	0.00196	0.0463	CcSEcCtD
Sucralfate—Venous thrombosis—Epirubicin—sarcoma	0.00177	0.0419	CcSEcCtD
Sucralfate—Phlebitis—Mitoxantrone—sarcoma	0.00173	0.0409	CcSEcCtD
Sucralfate—Venous thrombosis—Doxorubicin—sarcoma	0.00164	0.0388	CcSEcCtD
Sucralfate—Hyponatraemia—Vincristine—sarcoma	0.00154	0.0363	CcSEcCtD
Sucralfate—Hyponatraemia—Mitoxantrone—sarcoma	0.0015	0.0354	CcSEcCtD
Sucralfate—Phlebitis—Etoposide—sarcoma	0.00144	0.034	CcSEcCtD
Sucralfate—ALB—testis—sarcoma	0.00139	0.00494	CbGeAlD
Sucralfate—Lung disorder—Epirubicin—sarcoma	0.00135	0.032	CcSEcCtD
Sucralfate—ALB—liver—sarcoma	0.00132	0.00467	CbGeAlD
Sucralfate—Lung disorder—Doxorubicin—sarcoma	0.00125	0.0296	CcSEcCtD
Sucralfate—Extravasation—Epirubicin—sarcoma	0.0011	0.0259	CcSEcCtD
Sucralfate—Extravasation—Doxorubicin—sarcoma	0.00101	0.024	CcSEcCtD
Sucralfate—ALB—lymph node—sarcoma	0.00101	0.00358	CbGeAlD
Sucralfate—Infection—Thiotepa—sarcoma	0.000842	0.0199	CcSEcCtD
Sucralfate—Oedema—Dactinomycin—sarcoma	0.000841	0.0199	CcSEcCtD
Sucralfate—Infection—Dactinomycin—sarcoma	0.000836	0.0198	CcSEcCtD
Sucralfate—Phlebitis—Epirubicin—sarcoma	0.000806	0.0191	CcSEcCtD
Sucralfate—Oedema—Vincristine—sarcoma	0.000752	0.0178	CcSEcCtD
Sucralfate—Infection—Vincristine—sarcoma	0.000747	0.0177	CcSEcCtD
Sucralfate—Phlebitis—Doxorubicin—sarcoma	0.000746	0.0177	CcSEcCtD
Sucralfate—Oedema—Mitoxantrone—sarcoma	0.000732	0.0173	CcSEcCtD
Sucralfate—Infection—Mitoxantrone—sarcoma	0.000727	0.0172	CcSEcCtD
Sucralfate—Hyponatraemia—Epirubicin—sarcoma	0.000697	0.0165	CcSEcCtD
Sucralfate—Body temperature increased—Thiotepa—sarcoma	0.00067	0.0159	CcSEcCtD
Sucralfate—Body temperature increased—Dactinomycin—sarcoma	0.000665	0.0157	CcSEcCtD
Sucralfate—Hyponatraemia—Doxorubicin—sarcoma	0.000645	0.0153	CcSEcCtD
Sucralfate—Infection—Etoposide—sarcoma	0.000605	0.0143	CcSEcCtD
Sucralfate—Body temperature increased—Vincristine—sarcoma	0.000594	0.0141	CcSEcCtD
Sucralfate—Body temperature increased—Mitoxantrone—sarcoma	0.000579	0.0137	CcSEcCtD
Sucralfate—Body temperature increased—Etoposide—sarcoma	0.000481	0.0114	CcSEcCtD
Sucralfate—Oedema—Epirubicin—sarcoma	0.000341	0.00808	CcSEcCtD
Sucralfate—Infection—Epirubicin—sarcoma	0.000339	0.00802	CcSEcCtD
Sucralfate—Oedema—Doxorubicin—sarcoma	0.000316	0.00747	CcSEcCtD
Sucralfate—Infection—Doxorubicin—sarcoma	0.000314	0.00742	CcSEcCtD
Sucralfate—Body temperature increased—Epirubicin—sarcoma	0.00027	0.00639	CcSEcCtD
Sucralfate—Body temperature increased—Doxorubicin—sarcoma	0.00025	0.00591	CcSEcCtD
Sucralfate—FGF2—Downstream signal transduction—HRAS—sarcoma	0.000141	0.000214	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—HRAS—sarcoma	0.000141	0.000214	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—MDM2—sarcoma	0.000141	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—HRAS—sarcoma	0.000141	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—sarcoma	0.00014	0.000212	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ANGPT2—sarcoma	0.00014	0.000212	CbGpPWpGaD
Sucralfate—EGF—Immune System—PDGFRA—sarcoma	0.00014	0.000212	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—sarcoma	0.000139	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Disease—ENO2—sarcoma	0.000138	0.000209	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000137	0.000208	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000136	0.000207	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FLT1—sarcoma	0.000132	0.0002	CbGpPWpGaD
Sucralfate—EGF—Disease—FOXO1—sarcoma	0.000131	0.000199	CbGpPWpGaD
Sucralfate—EGF—Disease—PDGFRB—sarcoma	0.000131	0.000199	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—sarcoma	0.000131	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000131	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—sarcoma	0.000131	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—sarcoma	0.00013	0.000197	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTPRC—sarcoma	0.00013	0.000197	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PLCG1—sarcoma	0.00013	0.000197	CbGpPWpGaD
Sucralfate—EGF—Disease—PDGFRA—sarcoma	0.000129	0.000196	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000129	0.000196	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000129	0.000195	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—sarcoma	0.000128	0.000194	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—JUN—sarcoma	0.000127	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CREB1—sarcoma	0.000127	0.000193	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—SRC—sarcoma	0.000127	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PLCG1—sarcoma	0.000127	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—SRC—sarcoma	0.000127	0.000192	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CTNNB1—sarcoma	0.000126	0.000192	CbGpPWpGaD
Sucralfate—FGA—Disease—MDM2—sarcoma	0.000126	0.000192	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—sarcoma	0.000125	0.000189	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCR4—sarcoma	0.000125	0.000189	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KDR—sarcoma	0.000124	0.000189	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TLE1—sarcoma	0.000124	0.000188	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—sarcoma	0.000124	0.000188	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ATF1—sarcoma	0.000123	0.000187	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NRAS—sarcoma	0.000122	0.000185	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—NRAS—sarcoma	0.000122	0.000185	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KDR—sarcoma	0.000122	0.000185	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KDR—sarcoma	0.000122	0.000185	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—sarcoma	0.000121	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ATF1—sarcoma	0.000121	0.000183	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000119	0.00018	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP2—sarcoma	0.000118	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—KIT—sarcoma	0.000118	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Disease—PLCG1—sarcoma	0.000117	0.000178	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000116	0.000176	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KIT—sarcoma	0.000115	0.000174	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—SRC—sarcoma	0.000114	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KIT—sarcoma	0.000113	0.000172	CbGpPWpGaD
Sucralfate—FGF2—Disease—CXCR4—sarcoma	0.000113	0.000171	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KIT—sarcoma	0.000112	0.00017	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KIT—sarcoma	0.000112	0.00017	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFC—sarcoma	0.000112	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CREB1—sarcoma	0.000112	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—sarcoma	0.000111	0.000169	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—sarcoma	0.00011	0.000167	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NRAS—sarcoma	0.00011	0.000167	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—SRC—sarcoma	0.00011	0.000167	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CREB1—sarcoma	0.000109	0.000166	CbGpPWpGaD
Sucralfate—FGA—Disease—CTNNB1—sarcoma	0.000109	0.000165	CbGpPWpGaD
Sucralfate—EGF—Immune System—KIT—sarcoma	0.000108	0.000164	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CREB1—sarcoma	0.000108	0.000163	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CREB1—sarcoma	0.000107	0.000162	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CREB1—sarcoma	0.000107	0.000162	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NRAS—sarcoma	0.000106	0.00016	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—KRAS—sarcoma	0.000105	0.000159	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—KRAS—sarcoma	0.000105	0.000159	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFC—sarcoma	0.000104	0.000158	CbGpPWpGaD
Sucralfate—EGF—Immune System—CREB1—sarcoma	0.000103	0.000157	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—sarcoma	0.0001	0.000152	CbGpPWpGaD
Sucralfate—EGF—Disease—KIT—sarcoma	0.0001	0.000152	CbGpPWpGaD
Sucralfate—FGA—Disease—SRC—sarcoma	9.85e-05	0.000149	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1R—sarcoma	9.66e-05	0.000147	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—sarcoma	9.62e-05	0.000146	CbGpPWpGaD
Sucralfate—EGF—Disease—CREB1—sarcoma	9.53e-05	0.000145	CbGpPWpGaD
Sucralfate—FGA—Disease—NRAS—sarcoma	9.47e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—KRAS—sarcoma	9.46e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—sarcoma	9.34e-05	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MDM2—sarcoma	9.28e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FOXO1—sarcoma	9.2e-05	0.00014	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PDGFRB—sarcoma	9.18e-05	0.000139	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—KRAS—sarcoma	9.09e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CTNNB1—sarcoma	9.06e-05	0.000137	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PDGFRA—sarcoma	9.04e-05	0.000137	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MDM2—sarcoma	9.03e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FOXO1—sarcoma	9e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PDGFRB—sarcoma	8.99e-05	0.000136	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—sarcoma	8.93e-05	0.000136	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—sarcoma	8.92e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—MDM2—sarcoma	8.91e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PDGFRA—sarcoma	8.85e-05	0.000134	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MDM2—sarcoma	8.84e-05	0.000134	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MDM2—sarcoma	8.84e-05	0.000134	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—sarcoma	8.82e-05	0.000134	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLCG1—sarcoma	8.82e-05	0.000134	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—sarcoma	8.63e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Immune System—MDM2—sarcoma	8.54e-05	0.00013	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FLT1—sarcoma	8.35e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Disease—FOXO1—sarcoma	8.31e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Disease—PDGFRB—sarcoma	8.3e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PLCG1—sarcoma	8.2e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—SRC—sarcoma	8.19e-05	0.000124	CbGpPWpGaD
Sucralfate—FGF2—Disease—PDGFRA—sarcoma	8.17e-05	0.000124	CbGpPWpGaD
Sucralfate—FGA—Disease—KRAS—sarcoma	8.15e-05	0.000124	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2—sarcoma	8.07e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—JUN—sarcoma	8.06e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—sarcoma	8.04e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CTNNB1—sarcoma	8e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—sarcoma	7.98e-05	0.000121	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2—sarcoma	7.9e-05	0.00012	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2—sarcoma	7.9e-05	0.00012	CbGpPWpGaD
Sucralfate—EGF—Disease—MDM2—sarcoma	7.88e-05	0.00012	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCR4—sarcoma	7.88e-05	0.00012	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NRAS—sarcoma	7.88e-05	0.00012	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—sarcoma	7.86e-05	0.000119	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—JUN—sarcoma	7.85e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ATF1—sarcoma	7.79e-05	0.000118	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CTNNB1—sarcoma	7.79e-05	0.000118	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—sarcoma	7.72e-05	0.000117	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—sarcoma	7.7e-05	0.000117	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—sarcoma	7.7e-05	0.000117	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—JUN—sarcoma	7.69e-05	0.000117	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—JUN—sarcoma	7.69e-05	0.000117	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CTNNB1—sarcoma	7.63e-05	0.000116	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CTNNB1—sarcoma	7.63e-05	0.000116	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2—sarcoma	7.63e-05	0.000116	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KDR—sarcoma	7.61e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Immune System—JUN—sarcoma	7.42e-05	0.000113	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTNNB1—sarcoma	7.36e-05	0.000112	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—SRC—sarcoma	7.23e-05	0.00011	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—sarcoma	7.18e-05	0.000109	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SRC—sarcoma	7.04e-05	0.000107	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KIT—sarcoma	7.01e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NRAS—sarcoma	6.96e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—SRC—sarcoma	6.94e-05	0.000105	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—sarcoma	6.93e-05	0.000105	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SRC—sarcoma	6.89e-05	0.000105	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SRC—sarcoma	6.89e-05	0.000105	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KIT—sarcoma	6.86e-05	0.000104	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—sarcoma	6.85e-05	0.000104	CbGpPWpGaD
Sucralfate—EGF—Disease—CTNNB1—sarcoma	6.8e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—KRAS—sarcoma	6.78e-05	0.000103	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NRAS—sarcoma	6.77e-05	0.000103	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—sarcoma	6.72e-05	0.000102	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—sarcoma	6.72e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NRAS—sarcoma	6.68e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CREB1—sarcoma	6.67e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Immune System—SRC—sarcoma	6.66e-05	0.000101	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NRAS—sarcoma	6.63e-05	0.000101	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NRAS—sarcoma	6.63e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CREB1—sarcoma	6.53e-05	9.91e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	6.51e-05	9.88e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—NRAS—sarcoma	6.4e-05	9.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—sarcoma	6.34e-05	9.62e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—KIT—sarcoma	6.33e-05	9.61e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—sarcoma	6.31e-05	9.57e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—sarcoma	6.18e-05	9.38e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—sarcoma	6.18e-05	9.38e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—sarcoma	6.17e-05	9.36e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—SRC—sarcoma	6.14e-05	9.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1R—sarcoma	6.11e-05	9.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—sarcoma	6.09e-05	9.24e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—sarcoma	6.04e-05	9.17e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—sarcoma	6.04e-05	9.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CREB1—sarcoma	6.03e-05	9.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—KRAS—sarcoma	5.99e-05	9.09e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—NRAS—sarcoma	5.91e-05	8.97e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—sarcoma	5.83e-05	8.85e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KRAS—sarcoma	5.83e-05	8.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FOXO1—sarcoma	5.82e-05	8.83e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDGFRB—sarcoma	5.81e-05	8.82e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—sarcoma	5.76e-05	8.75e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KRAS—sarcoma	5.75e-05	8.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDGFRA—sarcoma	5.72e-05	8.68e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KRAS—sarcoma	5.71e-05	8.66e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KRAS—sarcoma	5.71e-05	8.66e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	5.68e-05	8.62e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	5.53e-05	8.4e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MDM2—sarcoma	5.52e-05	8.37e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—KRAS—sarcoma	5.51e-05	8.36e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—sarcoma	5.51e-05	8.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MDM2—sarcoma	5.4e-05	8.2e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—sarcoma	5.39e-05	8.17e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—sarcoma	5.18e-05	7.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—sarcoma	5.09e-05	7.72e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—KRAS—sarcoma	5.09e-05	7.72e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—sarcoma	5.07e-05	7.7e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—sarcoma	5.07e-05	7.7e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MDM2—sarcoma	4.99e-05	7.57e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—sarcoma	4.95e-05	7.52e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2—sarcoma	4.93e-05	7.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—sarcoma	4.89e-05	7.42e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—sarcoma	4.85e-05	7.36e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—sarcoma	4.85e-05	7.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2—sarcoma	4.83e-05	7.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KDR—sarcoma	4.81e-05	7.31e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—sarcoma	4.81e-05	7.29e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—JUN—sarcoma	4.8e-05	7.28e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CTNNB1—sarcoma	4.76e-05	7.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—JUN—sarcoma	4.7e-05	7.13e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—sarcoma	4.68e-05	7.11e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTNNB1—sarcoma	4.66e-05	7.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KIT—sarcoma	4.43e-05	6.73e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—sarcoma	4.32e-05	6.56e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SRC—sarcoma	4.3e-05	6.53e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CTNNB1—sarcoma	4.3e-05	6.53e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CREB1—sarcoma	4.22e-05	6.41e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ENO2—sarcoma	4.22e-05	6.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SRC—sarcoma	4.21e-05	6.39e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—sarcoma	4.19e-05	6.36e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HBA1—sarcoma	4.19e-05	6.36e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NRAS—sarcoma	4.14e-05	6.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NRAS—sarcoma	4.05e-05	6.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SRC—sarcoma	3.89e-05	5.9e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—sarcoma	3.86e-05	5.85e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—sarcoma	3.77e-05	5.72e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NRAS—sarcoma	3.74e-05	5.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—sarcoma	3.69e-05	5.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLCG1—sarcoma	3.58e-05	5.43e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KRAS—sarcoma	3.56e-05	5.41e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MDM2—sarcoma	3.49e-05	5.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KRAS—sarcoma	3.49e-05	5.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—sarcoma	3.48e-05	5.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—sarcoma	3.41e-05	5.17e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2—sarcoma	3.36e-05	5.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—KRAS—sarcoma	3.22e-05	4.89e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—sarcoma	3.17e-05	4.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2—sarcoma	3.12e-05	4.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—sarcoma	3.04e-05	4.62e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—JUN—sarcoma	3.04e-05	4.61e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—sarcoma	3.03e-05	4.6e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CTNNB1—sarcoma	3.01e-05	4.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—sarcoma	2.96e-05	4.5e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SRC—sarcoma	2.93e-05	4.44e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—sarcoma	2.85e-05	4.33e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NRAS—sarcoma	2.82e-05	4.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—sarcoma	2.74e-05	4.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SRC—sarcoma	2.72e-05	4.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—sarcoma	2.65e-05	4.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NRAS—sarcoma	2.62e-05	3.98e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—sarcoma	2.44e-05	3.7e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—KRAS—sarcoma	2.43e-05	3.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—sarcoma	2.39e-05	3.62e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KRAS—sarcoma	2.25e-05	3.42e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—sarcoma	2.16e-05	3.27e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—sarcoma	2.06e-05	3.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—sarcoma	2e-05	3.04e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—sarcoma	1.92e-05	2.91e-05	CbGpPWpGaD
